Imaging in nasopharyngeal carcinoma: the value of 18-Florine Fluorodeoxyglucose PET/CT in comparison to conventional imaging modalities CT and MRI

Chien YC, Chen JY, Liu MY, Yang HI, Hsu MM, Chen CJ, et al. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med 2001; 345: 1877-82.10.1056/NEJMoa011610Search in Google Scholar

Mutirangura A, Tanunyutthawongese C, Pornthanakarem W, Kerekhanjanarong V, Sriuranpong V, Yenrundi S, et al. Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection. Brit J Cancer 1997: 76: 770-6.10.1038/bjc.1997.460Search in Google Scholar

Krishna SM, James S, Kattoor J, Balaram P. Serum EBV DNA as a biomarker in primary nasopharyngeal carcinoma of Indian origin. Jpn J Clin Oncol 2004; 34: 307-11.10.1093/jjco/hyh055Search in Google Scholar

Mutirangura A, Pornthanakanem W, Theamboonlers A, Sriuranpong V, Lertsanguansinchi P, Yenrudi S, et al. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma. Clin Cancer Res 1998; 4: 665-9.Search in Google Scholar

Tong JH, Tsang RK, Lo KW, Woo JK, Kwong J, Chan MW, et al. Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma. Clin Cancer Res 2002; 8: 2612-9.Search in Google Scholar

Chang YS, Tyan YS, Liu ST, Tsai MS, Pao CC. Detection of Epstein-Barr virus DNA sequences in nasopharyngeal carcinoma cells by enzymatic DNA amplification. J Clin Microbiol 1990; 28: 2398-402.10.1128/jcm.28.11.2398-2402.1990Search in Google Scholar

Macdonald MR, Le KT, Freeman J, Hui MF, Cheung RK, Dosch HM. A majority of inverted sinonasal papillomas carries Epstein-Barr virus genomes. Cancer 1995; 75: 2307-12.10.1002/1097-0142(19950501)75:9<2307::AID-CNCR2820750920>3.0.CO;2-ZSearch in Google Scholar

Liavaag PG, Cheung RK, Kerrebijn JD, Freeman JL, Irish JC, Dosch HM. The physiologic reservoir of Epstein-Barr virus does not map to upper aerodigestive tissues. Laryngoscope 1998; 108: 42-6.10.1097/00005537-199801000-00008Search in Google Scholar

World Health Organisation International Agency for Research on Cancer (IARC) monographs on the evaluation of carcinogenic risks to humans Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8. Summary of data reported and evaluation Epstein-Barr virus Kaposi's sarcoma 1997; 70: 47.Search in Google Scholar

Twu CW, Wang WY, Liang WM, Jan JS, Jiang RS, Chao J, et al. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2007; 67: 130-7.10.1016/j.ijrobp.2006.07.012Search in Google Scholar

Strojan P. Cysteine cathepsins and stefins in head and neck cancer: an update of clinical studies. Radiol Oncol 2008; 42: 69-81.10.2478/v10019-008-0006-4Search in Google Scholar

Yip KW, Shi W, Pintilie M, Martin JD, Mocanu JD, Wong D, et al. Prognostic significance of the Epstein-Barrvirus, p53, Bcl-2, and surviving in nasopharyngeal cancer. Clin Cancer Res 2006; 12: 5726-32.10.1158/1078-0432.CCR-06-0571Search in Google Scholar

Avazpour I, Roslan RE, Bayat P, Saripan MI, Nordin AJ, Raja Abdullah RSA. Segmenting CT images of bronchogenic carcinoma with bone metastases using PET intensity markers approach. Radiol Oncol 2009; 43: 180-86.10.2478/v10019-009-0023-ySearch in Google Scholar

Feinmesser R, Miyazaki I, Cheung R, Freeman JL, Noyek AM, Dosch HM. Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration. N Engl J Med 1992; 326: 17-21.10.1056/NEJM199201023260103Search in Google Scholar

Chan SC, Ng SH, Chang JT, Lin CY, Chen YC, Chang YC, et al. Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging. Eur J Nucl Med Mol Imaging 2006; 33: 1032-40.10.1007/s00259-005-0054-6Search in Google Scholar

Ng SH, Joseph CT, Chan SC, Ko SF, Wang HM, Liao CT, et al. Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence. J Nucl Med 2004; 45: 1669-76.Search in Google Scholar

Tsai MH, Shiau YC, Kao CH, Shen YY, Lin CC, Lee CC. Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy. J Cancer Res Clin Oncol 2002; 128: 279-82.10.1007/s00432-002-0341-6Search in Google Scholar

Kao CH, Shiau YC, Shen YY, Yen RF. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography: comparison with 18-fluoro-2-deoxyglucose positron emission tomography. Cancer 2002; 94: 1981-6.10.1002/cncr.10400Search in Google Scholar

Wong WL, Chevretton EB, McGurk M, Hussain K, Davis J, Beaney R, et al. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. Clin Otolaryngol 1997; 22: 209-14.10.1046/j.1365-2273.1997.00852.xSearch in Google Scholar

Kao CH, Chang Lai SP, Chieng PU, Yen RF, Yen TC. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography. J Clin Oncol 1998; 16: 3550-5.10.1200/JCO.1998.16.11.3550Search in Google Scholar

Kao CH, Tsai SC, Wang JJ, Ho YJ, Yen RF, Ho ST. Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy. Cancer 2001; 92: 434-9.10.1002/1097-0142(20010715)92:2<434::AID-CNCR1339>3.0.CO;2-OSearch in Google Scholar

Tsai MH, Shiau YC, Kao CH, Shen YY, Lin CC, Lee CC. Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy. J Cancer Res Clin Oncol 2002; 128: 279-82.10.1007/s00432-002-0341-6Search in Google Scholar

Krause BJ, Beyer T, Bockisch A, Delbeke D, Kotzerke J, Minkov V, et al. FDG-PET/CT in oncology. German guideline. Nuklearmedizin 2007; 46: 291-301.10.3413/nukmed-282Search in Google Scholar

Chua DT, Sham JS, Kwong DL, Au GK, Choy DT. Retropharyngeal lymphadenopathy in patients with nasopharyngeal carcinoma: a computed tomography-based study. Cancer 1997; 9: 869-77.10.1002/(SICI)1097-0142(19970301)79:5<869::AID-CNCR1>3.0.CO;2-7Search in Google Scholar

Gutzeit A, Antoch G, Kühl H, Egelhof T, Fischer M, Hauth E, et al. Unknown primary tumors: detection with dual-modality PET/CT-initial experience. Radiology 2005; 234: 227-34.10.1148/radiol.234103155415564390Search in Google Scholar

Paulus P, Sambon A, Vivegnis D, Hustinx R, Moreau P, Collignon J, et al. ¹⁸FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients. Laryngoscope 1998; 108: 1578-83.10.1097/00005537-199810000-000299778305Search in Google Scholar

Ewald K, Mikosch P, Gallowitsch HJ, Kohlfurst S, Lind P. The value of imaging methods with emphasis on PET/CT in head and neck tumours: a comparison between a novel diagnostic regime using 18F-FDG PET and conventional techniques - own results and literature review. Imaging Decisions 2007; 2: 24-32.Search in Google Scholar